FibroBiologics Says USPTO Issues US Patent Entitled Methods And Compositions For Treatment Of Type 1 Diabetes Using Fibroblasts In Facilitation Of Islet Engraftment

Loading news article.

FibroBiologics Says USPTO Issues US Patent Entitled Methods And Compositions For Treatment Of Type 1 Diabetes Using Fibroblasts In Facilitation Of Islet Engraftment | WAPE

FibroBiologics Says USPTO Issues US Patent Entitled Methods And Compositions For Treatment Of Type 1 Diabetes Using Fibroblasts In Facilitation Of Islet Engraftment

Article summary

Related companies

Comments —